Granite Awarded First Phase of CMGC Contract in Alaska for Parks Highway Realignment
WATSONVILLE, Calif.–(BUSINESS WIRE)–Granite (NYSE:GVA) has been awarded a Federally funded $54 million contract to build the first of two construction... Read more.
Media Advisory: Check Presentation to Celebrate Housing Assistance for Veterans
***11:00 a.m., Wednesday, May 28, 8522 Glade Drive, Temple, Texas, 76502*** TEMPLE, Texas–(BUSINESS WIRE)–Representatives from the Federal Home Loan... Read more.
XP Inc. to Cancel Treasury Shares
SÃO PAULO–(BUSINESS WIRE)–XP Inc. (Nasdaq: XP), a leading, technology-driven platform and a trusted provider of low-fee financial products... Read more.
XP Inc. Reports First Quarter 2025 Results
SÃO PAULO–(BUSINESS WIRE)–XP Inc. (NASDAQ: XP) (“XP” or the “Company”), a leading tech-enabled platform and a trusted... Read more.
Acrisure Secures $2.1 Billion Funding Round Led by Bain Capital
Additional investors include Fidelity Management & Research Company, Apollo Funds, Gallatin Point and BDT & MSD Partners Financing values Acrisure at $32... Read more.
DOV Opens Office in South Korea, Marking Strategic Asia-Pacific Expansion
NEW YORK–(BUSINESS WIRE)–DOV Management, a New York-based investment firm specializing in alternative assets and structured opportunities, today announced... Read more.
KBRA Releases Research – Navigating Trade Winds: Tariff Impacts on Aviation ABS
NEW YORK–(BUSINESS WIRE)–#creditratingagency–KBRA releases research on the potential impacts of tariffs on the aviation asset-backed securities... Read more.
Tailor Raises $14 Million in First Close of Series A to Power the Next Generation of Composable ERP
Round led by ANRI to support Tailor’s growth in North America and Japan amid rising demand for agile enterprise systems SAN FRANCISCO–(BUSINESS WIRE)–#erp—Tailor,... Read more.
AM Best Downgrades Issuer Credit Ratings of Members of Nodak Insurance Group and NI Holdings, Inc.
OLDWICK, N.J.–(BUSINESS WIRE)–#insurance—AM Best has downgraded the Long-Term Issuer Credit Ratings (Long-Term ICR) to “a” (Excellent)... Read more.
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 2025
Company’s NSCLC drug program is focused on overcoming both mutational and non-mutational resistance to 3rd-generation EGFR inhibitors and outperforms other... Read more.